Alcobendas, Spain

Abel Roigé

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medlumics S.l.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Abel Roigé

Introduction

Abel Roigé is a notable inventor based in Alcobendas, Spain. He has made significant contributions to the field of optical analysis, particularly in the context of medical technology. His work focuses on enhancing the effectiveness of tissue ablation procedures through innovative systems and methods.

Latest Patents

Abel Roigé holds a patent for "Systems and methods for optical analysis and contact stability using ablation catheters." This patent describes systems and methods for performing optical signal analysis for tissue ablation using a catheter equipped with viewports. The method involves transmitting illumination toward target tissue via the viewport and receiving scattered illumination to generate measurement signals. It also includes determining whether the viewport is in contact with the target tissue based on optical measurements.

Career Highlights

Abel Roigé is associated with Medlumics S.L., a company that specializes in advanced medical technologies. His work at Medlumics has allowed him to contribute to the development of innovative solutions that improve patient outcomes in medical procedures.

Collaborations

Abel has collaborated with notable colleagues such as James L. Greene and Juan Sancho Durá. These collaborations have further enriched his work and contributed to advancements in the field.

Conclusion

Abel Roigé's innovative work in optical analysis and tissue ablation demonstrates his commitment to advancing medical technology. His contributions are paving the way for more effective and safer medical procedures.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…